You are here



The fourth edition of this program promoted by “la Caixa”, Barcelona Activa, Biocat, Genoma España and the Barcelona Chamber of Commerce was presented this morning.


Some 200,000 people in the United States and Europe would benefit from this drug to ease the side effects of a variety of chemotherapies.


Afterwards, a proactive public purchasing policy linked to the most innovative Catalan biotech companies will be presented to the Government of Catalonia.


Winter has 20 years of experience in the biotech sector and in international venture capital at companies like ERA Biotech, Sofinnova Partners and Furman Selz, Inc.


A spin-off of the University of Lleida has created two software programs that allow personalised monitoring via telephone and Internet.


It is the first company to be installed in the Parc Científic i Tecnològic de Terrassa. Its general manager, Marc Canales, says that "we are convinced that we can create a cluster of leading companies and create synergies".


Companies are eligible for the BioEmprenedorXXI award, which includes training, incubation, internationalization and funding actions to start up a business project.


It is for their product SOM-0525, an inhaler to treat asthma and chronic obstructive pulmonary disease (COPD).


They have just closed a deal to market a tumor marker for early detection of endometrial cancer with pharmaceutical company Reig-Jofré.


This spin-off, one of the runners-up for the BioEmprenedorXXI award, is developing a new therapy to treat sepsis. 25% of patients in ICUs develop this infection.